GGrantIndex
← Leaderboards

Felipe Samaniego

University Of Texas Md Anderson Can Ctr

$2,780,803
Attributed
$2,780,803
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $575.5K · FY200513
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$2,780,803 · 7

By mechanism

R21$1,373,551 · 4
R03$585,588 · 1
K22$472,824 · 1
K08$348,840 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Apoptosis

Research focus

ApoptosisLaboratory MouseMediatingCessation Of LifeComplexRegulationApoptoticSignal TransductionBinding (Molecular Function)ChemotherapyReceptorCellsBinding ProteinsLymphocyteMutantGenetically Modified AnimalsProteinsInhibitor/AntagonistCd95 AntigensEnzyme ActivityMalignant NeoplasmsCancer TherapyHematologic NeoplasmsCancer Cell

Grant awards (17)

Preservation of liver function through modulation of Fas-binding proteins$190,588
R03 · FY2013 · DK · contact PI
Cancer Cell Overexpression of Death Receptor Modulator$161,516
R21 · FY2013 · CA · contact PI
Cancer Cell Overexpression of Death Receptor Modulator$206,190
R21 · FY2012 · CA · contact PI
Preservation of liver function through modulation of Fas-binding proteins$197,500
R03 · FY2012 · DK · contact PI
PMLRARalpha and PML directly regulate Fas-mediated apoptosis in vivo$171,825
R21 · FY2012 · CA · contact PI
PMLRARalpha and PML directly regulate Fas-mediated apoptosis in vivo$206,190
R21 · FY2011 · CA · contact PI
Preservation of liver function through modulation of Fas-binding proteins$197,500
R03 · FY2011 · DK · contact PI
Targeting Fas Inhibitors in Cancer Therapy$166,671
R21 · FY2011 · CA · contact PI
Targeting Fas Inhibitors in Cancer Therapy$206,190
R21 · FY2010 · CA · contact PI
PKB/Akt Activation and Cell Survival with HIV-1 Tat$125,969
R21 · FY2006 · CA · contact PI
Lymphoid Transformation with Human Herpesvirus 8 K1$157,680
K22 · FY2005 · CA
PKB/Akt Activation and Cell Survival with HIV-1 Tat$129,000
R21 · FY2005 · CA
Lymphoid Transformation with Human Herpesvirus 8 K1$157,680
K22 · FY2004 · CA
Lymphoid Transformation with Human Herpesvirus 8 K1$157,464
K22 · FY2003 · CA
HIV 1 TATS PROMOTION OF KAPOSIS SARCOMA$119,880
K08 · FY2002 · CA
HIV 1 TATS PROMOTION OF KAPOSIS SARCOMA$119,880
K08 · FY2001 · CA
HIV 1 TATS PROMOTION OF KAPOSIS SARCOMA$109,080
K08 · FY2000 · CA